Clinical response in Japanese metastatic melanoma patients treated with peptide cocktail-pulsed dendritic cells
AUTOR(ES)
Akiyama, Yasuto
FONTE
BioMed Central
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=549033Documentos Relacionados
- Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial
- Fibrinogen: a novel predictor of responsiveness in metastatic melanoma patients treated with bio-chemotherapy: IMI (italian melanoma inter-group) trial
- Complete response of metastatic renal cancer with dendritic cell vaccine
- Induction of antigen-specific cytolytic T cells in situ in human melanoma by immunization with synthetic peptide-pulsed autologous antigen presenting cells.
- Clinical significance of BRAF mutations in metastatic melanoma